Tilray Inc (TLRY) - Cash Flow Conversion Efficiency

Latest as of February 2026: -0.014x

Based on the latest financial reports, Tilray Inc (TLRY) has a cash flow conversion efficiency ratio of -0.014x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-21.94 Million ≈ $-15.87 Million USD) by net assets (CA$1.53 Billion ≈ $1.10 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Tilray Inc (TLRY) defensive interval to measure how many days the company can operate on defensive assets alone.

Tilray Inc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Tilray Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tilray Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tilray Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Zhejiang Fuchunjiang Environmental Thermoelectric Co Ltd
SHE:002479
0.032x
Jensen-Group NV
BR:JEN
0.102x
Prime Medicine, Inc. Common Stock
NASDAQ:PRME
-0.557x
Zhejiang Dafeng Industrial Co Ltd
SHG:603081
0.052x
Hangzhou Chinastars Reflective Material Co.Ltd.
SHE:301077
N/A
Cheng Uei Precision Industry Co Ltd
TW:2392
0.146x
Sayona Mining Ltd
AU:SYA
0.041x
Mutares SE & Co. KGaA
XETRA:MUX
-0.145x

Annual Cash Flow Conversion Efficiency for Tilray Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Tilray Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Tilray Inc (TLRY) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-05-31 CA$1.49 Billion
≈ $1.08 Billion
CA$-94.60 Million
≈ $-68.43 Million
-0.064x -607.55%
2024-05-31 CA$3.44 Billion
≈ $2.49 Billion
CA$-30.91 Million
≈ $-22.36 Million
-0.009x -478.05%
2023-05-31 CA$3.33 Billion
≈ $2.41 Billion
CA$7.91 Million
≈ $5.72 Million
0.002x +105.95%
2022-05-31 CA$4.44 Billion
≈ $3.21 Billion
CA$-177.26 Million
≈ $-128.23 Million
-0.040x -298.55%
2021-05-31 CA$4.47 Billion
≈ $3.23 Billion
CA$-44.72 Million
≈ $-32.35 Million
-0.010x +86.24%
2020-05-31 CA$1.33 Billion
≈ $958.73 Million
CA$-96.43 Million
≈ $-69.76 Million
-0.073x -126.78%
2019-05-31 CA$1.28 Billion
≈ $926.63 Million
CA$-41.10 Million
≈ $-29.73 Million
-0.032x -566.53%
2018-05-31 CA$910.14 Million
≈ $658.38 Million
CA$-4.38 Million
≈ $-3.17 Million
-0.005x -124.75%
2017-05-31 CA$203.29 Million
≈ $147.06 Million
CA$3.95 Million
≈ $2.86 Million
0.019x +168.90%
2016-05-31 CA$26.85 Million
≈ $19.42 Million
CA$-757.62K
≈ $-548.05K
-0.028x +93.08%
2015-05-31 CA$10.74 Million
≈ $7.77 Million
CA$-4.38 Million
≈ $-3.17 Million
-0.408x -169.35%
2014-05-31 CA$271.84K
≈ $196.64K
CA$-41.16K
≈ $-29.78K
-0.151x 0.00%
2013-05-31 CA$271.84K
≈ $196.64K
CA$-41.16K
≈ $-29.78K
-0.151x -17.18%
2012-05-31 CA$333.15K
≈ $241.00K
CA$-43.05K
≈ $-31.14K
-0.129x --

About Tilray Inc

TO:TLRY Canada Drug Manufacturers - Specialty & Generic
Market Cap
$579.68 Million
CA$801.35 Million CAD
Market Cap Rank
#11631 Global
#339 in Canada
Share Price
CA$6.70
Change (1 day)
-0.59%
52-Week Range
CA$0.50 - CA$19.12
All Time High
CA$26.00
About

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more